login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
USA Market Overview
Canada Market Overview
Europe Market Overview
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Swing Trading Course
Account
Disclaimer
Affiliate
Contact
Privacy
BLUEPRINT MEDICINES CORP (BPMC) Stock News
USA
- NASDAQ:BPMC -
US09627Y1091
-
Common Stock
129.46
USD
+0.18 (+0.14%)
Last: 7/17/2025, 8:06:04 PM
129.5
USD
+0.04 (+0.03%)
After Hours:
7/17/2025, 8:06:04 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
BPMC Latest News, Press Relases and Analysis
All
Press Releases
a month ago - By: Ademi & Fruchter LLP
Shareholder Alert: The Ademi Firm Continues to Investigate the Blueprint Medicines Corporation Transaction
2 months ago - By: Ademi & Fruchter LLP
Shareholder Alert: The Ademi Firm Investigates the Blueprint Medicines Corporation Transaction
3 months ago - By: Benzinga
- Mentions:
AZN
SNY
Sanofi Expands Respiratory Vaccine Portfolio With UK Biotech Buy
3 months ago - By: Benzinga
What's Driving the Market Sentiment Around Blueprint Medicines?
4 months ago - By: Zacks Investment Research
- Mentions:
ACAD
Why Is Acadia (ACAD) Up 26.1% Since Last Earnings Report?
4 months ago - By: Kahn Swick & Foti, LLC
BLUEPRINT MEDICINES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Blueprint Medicines Corporation - BPMC
4 months ago - By: Halper Sadeh LLC
- Mentions:
SSBK
NYSE
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates BPMC, SVT, SSBK on Behalf of Shareholders
4 months ago - By: Blueprint Medicines Corporation
Blueprint Medicines Announces Data Reinforcing Sustained Clinical Efficacy and Well-Tolerated Safety Profile of Long-Term AYVAKIT®/AYVAKYT® (avapritinib) Treatment at 2025 EHA and EAACI Congresses
4 months ago - By: Yahoo Finance
- Mentions:
AAPL
UBS
DG
GS
...
Apple downgraded, Snowflake upgraded: Wall Street's top analyst calls
4 months ago - By: Halper Sadeh LLC
- Mentions:
VIGL
STR
STRM
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates VIGL, STR, BPMC, STRM on Behalf of Shareholders
4 months ago - By: Kahn Swick & Foti, LLC
BLUEPRINT MEDICINES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Blueprint Medicines Corporation - BPMC
4 months ago - By: Yahoo Finance
- Mentions:
PINS
JPM
WFC
RDDT
...
Reddit initiated, Pinterest upgraded: Wall Street's top analyst calls
4 months ago - By: Stocktwits
- Mentions:
JPM
Blueprint Medicines Stock Lands Several Downgrades After Sanofi’s Buyout Deal, But Retail Bulls Keep The Faith
4 months ago - By: Yahoo Finance
- Mentions:
SPY
QQQ
DX-Y
GC=F
...
Stock market today: Dow, S&P 500, Nasdaq close higher as US-China trade tensions flare up
4 months ago - By: Zacks Investment Research
- Mentions:
SNY
AMRN
Sanofi Signs a $9.5B Agreement to Acquire Blueprint Medicines
4 months ago - By: Yahoo Finance
- Mentions:
SNY
Sanofi to expand immunology offerings with Blueprint Medicines
4 months ago - By: Yahoo Finance
- Mentions:
GOOG
BA
X
STLD
...
Google to spend $500 million revamping compliance in shareholder settlement
4 months ago - By: Yahoo Finance
- Mentions:
SNY
NVS
REGN
Sanofi to Acquire Blueprint Medicines for up to $9.5 Billion to Expand Immunology Portfolio
4 months ago - By: Yahoo Finance
- Mentions:
DX-Y
GC=F
CRWD
AVGO
...
Stock market today: Dow, S&P 500, Nasdaq slip as US-China trade tensions flare up again
4 months ago - By: Yahoo Finance
- Mentions:
UNH
JPM
BLK
TSLA
...
Returning UnitedHealth CEO to face questions over pay and share price
4 months ago - By: Stocktwits
- Mentions:
SNY
Sanofi To Buy Blueprint Medicines For Up To $9.5B: Retail Sees More Acquisition Offers From European Pharma Companies
Please enable JavaScript to continue using this application.